These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34686390)

  • 1. Pain management during a bromelain-based selective enzymatic debridement in paediatric and adult burn patients.
    Claes KEY; Amar S; Hoeksema H; Kornhaber R; de Jong A; Monstrey S; Haik J; Biros E; Harats M
    Burns; 2022 May; 48(3):555-567. PubMed ID: 34686390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of NexoBrid™ enzymatic debridement and coagulation abnormalities.
    Capitelli-McMahon H; McCrossan S; Kershaw J; Muthayya P; Anwar MU; Carter A; Sloan B
    Burns; 2024 Feb; 50(1):123-131. PubMed ID: 37827936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
    Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
    Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review.
    Arkoulis N; Mabvuure NT; Smith A; Barnes DE
    J Plast Reconstr Aesthet Surg; 2021 Jun; 74(6):1402-1407. PubMed ID: 33388270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
    Rosenberg L; Krieger Y; Bogdanov-Berezovski A; Silberstein E; Shoham Y; Singer AJ
    Burns; 2014 May; 40(3):466-74. PubMed ID: 24074719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Burn wound treatment through enzymatic debridement: First experience in Switzerland].
    Osinga R; Steiger P; Giovanoli P; Plock JA; Mannil L
    Handchir Mikrochir Plast Chir; 2019 Apr; 51(2):80-85. PubMed ID: 29698995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Our initial learning curve in the enzymatic debridement of severely burned hands-Management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm.
    Schulz A; Perbix W; Shoham Y; Daali S; Charalampaki C; Fuchs PC; Schiefer J
    Burns; 2017 Mar; 43(2):326-336. PubMed ID: 28341257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma).
    Wickham N; Alexander KS; Fletcher A; O'Boyle C
    Scars Burn Heal; 2019; 5():2059513118821563. PubMed ID: 30719324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
    Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
    Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eschar removal by bromelain based enzymatic debridement (Nexobrid
    Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
    Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early non-excisional debridement of paediatric burns under general anaesthesia reduces time to re-epithelialisation and risk of skin graft.
    Griffin B; Bairagi A; Jones L; Dettrick Z; Holbert M; Kimble R
    Sci Rep; 2021 Dec; 11(1):23753. PubMed ID: 34887486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Bromelain-Based Enzymatic Debridement Combined with Laser Doppler Imaging and Healing of Burn Wounds.
    Korzeniowski T; Strużyna J; Torres K
    Med Sci Monit; 2022 Aug; 28():e936713. PubMed ID: 35918878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®.
    Sharaf A; Muthayya P
    Burns; 2022 Nov; 48(7):1618-1625. PubMed ID: 34973852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to start putting down the knife: A systematic review of burns excision tools of randomised and non-randomised trials.
    Edmondson SJ; Ali Jumabhoy I; Murray A
    Burns; 2018 Nov; 44(7):1721-1737. PubMed ID: 29456099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
    Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
    Ho W; Jones CD; Widdowson D; Bahia H
    J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: European consensus guidelines update.
    Hirche C; Kreken Almeland S; Dheansa B; Fuchs P; Governa M; Hoeksema H; Korzeniowski T; Lumenta DB; Marinescu S; Martinez-Mendez JR; Plock JA; Sander F; Ziegler B; Kneser U
    Burns; 2020 Jun; 46(4):782-796. PubMed ID: 32241591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic Versus Traditional Surgical Debridement of Severely Burned Hands: A Comparison of Selectivity, Efficacy, Healing Time, and Three-Month Scar Quality.
    Schulz A; Shoham Y; Rosenberg L; Rothermund I; Perbix W; Christian Fuchs P; Lipensky A; Schiefer JL
    J Burn Care Res; 2017; 38(4):e745-e755. PubMed ID: 28644207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helpful hints in deciding what and when to operate after enzymatic debridement.
    Claes KEY; De Decker I; Monstrey S; Shoham Y; Vyncke T; Depypere B; De Wolf E; Decuypere F; Lannau B; Hoeksema H
    Burns; 2023 Feb; 49(1):80-90. PubMed ID: 35177282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement.
    Heitzmann W; Fuchs PC; Schiefer JL
    Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33348927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.